Integer (NYSE:ITGR) Hits New 52-Week High – Still a Buy?

Posted by Francis Steltz on Sep 4th, 2026

Shares of Integer Holdings Corporation (NYSE:ITGR – Get Free Report) reached a new 52-week high on Friday . The company traded as high as $126.25 and last traded at $126.2050, with a volume of 152264 shares. The stock had previously closed at $125.50.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the company. Zacks Research upgraded Integer from a “strong sell” rating to a “hold” rating in a research note on Monday, July 20th. Piper Sandler downgraded Integer from an “overweight” rating to a “hold” rating and set a $127.00 price objective for the company. in a research report on Monday, August 3rd. Benchmark lowered Integer from a “buy” rating to a “hold” rating in a report on Thursday, August 13th. Truist Financial cut Integer from a “buy” rating to a “hold” rating and boosted their price objective for the company from $110.00 to $127.00 in a research report on Monday, August 3rd. Finally, Raymond James Financial lowered Integer from a “moderate buy” rating to a “hold” rating in a research note on Monday, August 3rd. One analyst has rated the stock with a Buy rating and thirteen have given a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $109.86.

Get Our Latest Research Report on ITGR

Integer Stock Performance

The company has a quick ratio of 2.41, a current ratio of 3.73 and a debt-to-equity ratio of 0.75. The stock has a fifty day simple moving average of $110.33 and a 200-day simple moving average of $95.65. The company has a market capitalization of $4.30 billion, a P/E ratio of 34.52, a PEG ratio of 2.36 and a beta of 0.62.

Integer (NYSE:ITGR – Get Free Report) last posted its earnings results on Monday, August 3rd. The medical equipment provider reported $1.60 earnings per share for the quarter, topping the consensus estimate of $1.38 by $0.22. The business had revenue of $464.11 million for the quarter, compared to analyst estimates of $451.07 million. Integer had a net margin of 6.97% and a return on equity of 12.79%. The firm’s quarterly revenue was down 2.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.55 EPS. Equities analysts forecast that Integer Holdings Corporation will post 6.14 EPS for the current year.

Institutional Trading of Integer

Several hedge funds have recently modified their holdings of the company. Vanguard Group Inc. boosted its holdings in shares of Integer by 0.4% in the 4th quarter. Vanguard Group Inc. now owns 3,886,150 shares of the medical equipment provider’s stock worth $304,791,000 after acquiring an additional 14,465 shares in the last quarter. California State Teachers Retirement System increased its holdings in Integer by 8,977.7% during the 2nd quarter. California State Teachers Retirement System now owns 3,702,956 shares of the medical equipment provider’s stock valued at $346,041,000 after purchasing an additional 3,662,164 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in Integer by 6.5% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,484,396 shares of the medical equipment provider’s stock valued at $130,620,000 after purchasing an additional 90,277 shares in the last quarter. State Street Corp raised its position in Integer by 3.7% in the 4th quarter. State Street Corp now owns 1,371,767 shares of the medical equipment provider’s stock valued at $107,588,000 after purchasing an additional 48,463 shares during the last quarter. Finally, Viking Global Investors LP raised its position in Integer by 9.1% in the 2nd quarter. Viking Global Investors LP now owns 1,283,965 shares of the medical equipment provider’s stock valued at $157,889,000 after purchasing an additional 106,692 shares during the last quarter. Institutional investors and hedge funds own 99.29% of the company’s stock.

Integer Company Profile

(Get Free Report)

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.